Keyphrases
Growth Factors
100%
Antimicrobial
100%
Medicare Database
100%
Elderly Patients with Cancer
100%
Medicare
75%
Breast Cancer
75%
Chemotherapy
75%
Non-Hodgkin Lymphoma
75%
Lung Cancer
50%
Clinical Practice
50%
Granulocyte Colony-stimulating Factor (G-CSF)
50%
Elderly Patients
50%
Febrile Neutropenia
50%
Reimbursement
25%
Older Adults
25%
Prophylactic Use
25%
Medicaid
25%
Chemotherapy Regimen
25%
Antibiotic Use
25%
Antibiotics
25%
Fee-for-service
25%
Supportive Care
25%
Antimicrobial Use
25%
Retrospective Cohort Study
25%
Treatment Costs
25%
Service System
25%
Age Groups
25%
Cost Reduction
25%
Usage Patterns
25%
Seeking Treatment
25%
Risk Category
25%
Potentially Toxic
25%
Payers
25%
Associated Comorbidities
25%
Comorbidity Burden
25%
Cancer Lung
25%
Care Bundle
25%
Developing Trend
25%
Chemotherapy-induced Myelosuppression
25%
Private Insurers
25%
Chemotherapy Cycles
25%
Hodgkin Cycle
25%
Nursing and Health Professions
Medicare
100%
Elderly Patient
100%
Growth Factor
100%
Nonhodgkin Lymphoma
75%
Breast Cancer
75%
Clinical Practice
50%
Granulocyte Colony Stimulating Factor
50%
Lung Cancer
50%
Febrile Neutropenia
50%
Comorbidity
50%
Physician
25%
Reimbursement
25%
Care Bundle
25%
Antiinfective Agent
25%
Cohort Analysis
25%
Bone Marrow Suppression
25%
Medicine and Dentistry
Chemotherapy
100%
Medicare
100%
Elderly Patient
100%
Growth Factor
100%
Breast Cancer
60%
Non-Hodgkin Lymphoma
60%
Lung Cancer
40%
Granulocyte Colony Stimulating Factor
40%
Febrile Neutropenia
40%
Comorbidity
40%
Health Care Cost
20%
Antiinfective Agent
20%
Antibiotics
20%
Retrospective Cohort Study
20%
Supportive Care
20%
Bone Marrow Suppression
20%
Chemotherapy Regimens
20%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Growth Factor
100%
Malignant Neoplasm
100%
Breast Cancer
60%
Nonhodgkin Lymphoma
60%
Lung Cancer
40%
Granulocyte Colony Stimulating Factor
40%
Febrile Neutropenia
40%
Comorbidity
40%
Cohort Study
20%
Antibiotics
20%
Antiinfective Agent
20%
Chemotherapy Regimens
20%
Bone Marrow Suppression
20%